中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line

文献类型:期刊论文

作者Lu, Jin-Jian1,2; Chen, Si-Meng1; Ding, Jian1; Meng, Ling-Hua1
刊名MOLECULAR AND CELLULAR BIOCHEMISTRY
出版日期2012-01
卷号360期号:1-2页码:329-337
关键词Dihydroartemisinin Resistant Proteomics Anti-tumor HCT116
ISSN号0300-8177
DOI10.1007/s11010-011-1072-2
文献子类Article
英文摘要Dihydroartemisinin (DHA) is an important artemisinin derivative and presents profound anti-tumor potential. A DHA-resistant cell line named HCT116/R derived from colon carcinoma cell line HCT116 was established in our previous study. Herein, we found that HCT116/R cells were much more resistant to DHA- or artesunate-induced proliferation inhibition and more tolerant to DHA-induced cell cycle arrest and apoptosis compared with those of the parent HCT116 cells. The protein levels of P-glycoprotein and MDR-associated protein 1 and the accumulation of doxorubicin in cells were similar in both cell lines. Moreover, HCT116/R cells were still sensitive to camptothecin- and doxorubicin-induced cell growth inhibition. To further explore the characterization of HCT116/R cell line, a proteomic study employing two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry was performed. Eight different expressed proteins between the two cell lines were identified including some heat shock proteins, annexins, etc. This study not only indicates that exposure to DHA may not induce a tumor multi-drug-resistant phenotype but also affords new clues for the further investigation of the anti-cancer mechanisms of DHA and other artemisinin derivatives.
WOS关键词PANCREATIC-CANCER CELLS ; OVARIAN-CANCER ; IN-VITRO ; BORTEZOMIB RESISTANCE ; MULTIDRUG-RESISTANCE ; PLATINUM-RESISTANCE ; PROTEOMIC ANALYSIS ; LEUKEMIA-CELLS ; ARTEMISININ ; APOPTOSIS
资助项目National Natural Science of China[81001450]
WOS研究方向Cell Biology
语种英语
WOS记录号WOS:000297722800035
出版者SPRINGER
源URL[http://119.78.100.183/handle/2S10ELR8/278296]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Ding, Jian
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
2.Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou 310053, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Lu, Jin-Jian,Chen, Si-Meng,Ding, Jian,et al. Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line[J]. MOLECULAR AND CELLULAR BIOCHEMISTRY,2012,360(1-2):329-337.
APA Lu, Jin-Jian,Chen, Si-Meng,Ding, Jian,&Meng, Ling-Hua.(2012).Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.MOLECULAR AND CELLULAR BIOCHEMISTRY,360(1-2),329-337.
MLA Lu, Jin-Jian,et al."Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line".MOLECULAR AND CELLULAR BIOCHEMISTRY 360.1-2(2012):329-337.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。